Jason Jerabek, DO
Family Medicine · Charleston, ILNPI 1396853008
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 351 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,358 and has fallen 60.5% since, to $537 in 2025. Among family medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 351 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$467
- GSK$382
- Pfizer$362
- Boehringer Ingelheim$335
- plus $2K from 31 others
What the payments were for
- Food & beverage$6,078100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 113 | $1,351 |
| AstraZeneca | 28 | $1,058 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 27 | $467 |
| GSK | 39 | $382 |
| Pfizer | 23 | $362 |
| Boehringer Ingelheim | 15 | $335 |
| Johnson & Johnson | 17 | $308 |
| Lilly USA, LLC | 19 | $306 |
| Teva Pharmaceuticals USA, Inc. | 10 | $165 |
| Merck | 10 | $158 |
| Alkermes, Inc. | 2 | $136 |
| Amgen | 2 | $123 |
| Collegium Pharmaceutical, Inc. | 2 | $109 |
| Astellas Pharma US Inc | 6 | $96 |
| Grifols USA, LLC | 5 | $66 |
| Eisai Inc. | 4 | $52 |
| Scilex Pharmaceuticals Inc. | 1 | $49 |
| Bayer | 3 | $47 |
| Antares Pharma, Inc. | 3 | $47 |
| Emergent Biosolutions Inc. | 1 | $45 |
| Tactile Systems Technology Inc | 1 | $40 |
| Supernus Pharmaceuticals, Inc. | 3 | $39 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $38 |
| Kaleo, Inc. | 1 | $38 |
| Neurocrine Biosciences, Inc. | 2 | $31 |
| Exact Sciences | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Baudax Bio Inc. | 1 | $19 |
| Clarus Therapeutics Inc. | 1 | $19 |
| Itamar Medical Inc | 1 | $17 |
| Ardelyx, Inc. | 1 | $17 |
| Viatris Specialty LLC | 1 | $15 |
| Verona Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,078 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 111 | $83,628 |
| EliquisApixaban | 97 | $80,456 |
| RybelsusSemaglutide | 61 | $67,871 |
| OzempicSemaglutide | 71 | $66,789 |
| LinzessLinaclotide | 103 | $63,141 |
| JardianceEmpagliflozin | 51 | $44,582 |
| JanuviaSitagliptin Phosphate | 69 | $44,430 |
| FarxigaDapagliflozin Propanediol | 14 | $21,926 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 33 | $21,879 |
| ProliaDenosumab | 12 | $21,312 |
| MounjaroTirzepatide | 18 | $19,163 |
| VraylarCariprazine Hcl | 11 | $18,768 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 32 | $14,803 |
| MyrbetriqMirabegron | 16 | $12,756 |
| Breo ElliptaFluticasone/Vilanterol | 31 | $12,325 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $1,351 | $134,660132 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $382 | $110,756174 claims |
| PfizerEliquis | $362 | $80,45697 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $335 | $56,40073 claims |
| MerckJanuvia | $158 | $44,43069 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,058 | $43,80547 claims |
| AmgenProlia | $123 | $21,31212 claims |
| Lilly USA, LLCMounjaro | $306 | $19,16318 claims |
| Astellas Pharma US IncMyrbetriq | $96 | $12,75616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Charleston
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.